A nearly decade-long study revealed that a once-a-day pill can reduce the risk of death from lung cancer by more than half, offering hope for improved patient outcomes and potentially saving millions of lives. Recently published in the New England Journal of Medicine (NEJM), the research involved 682 patients, including those diagnosed with non-small cell lung cancer (NSCLC),…

A recent randomized crossover trial uncovered a potential breakthrough for patients with advanced non-small cell lung cancer (NSCLC). The study suggests that opting for a fuller breakfast, as opposed to a low-fat breakfast, may significantly increase the concentration of a key treatment, alectinib, in the blood. This promising finding may potentially translate into improved survival…

Lung cancer is the leading cancer killer and the most common type of cancer in Hong Kong. In a study, Professor Tony S.K. Mok of The Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine) and  an international team of experts in lung cancer, found that combining the immunotherapy drugs tremelimumab and durvalumab…

Lung cancer is often called “the silent killer,” because it can go unnoticed until reaching advanced stages when death is inevitable. According to National Cancer Institute, 65.8 percent of lung cancer cases were diagnosed at a late stage, surpassing other common cancers like colon cancer, breast cancer, and prostate cancer. (Data Source: National Cancer Institute)…

Lung cancer ranks as the No.1 killer of all cancers globally. The main treatment method of Western medicine for non-small cell lung cancer, the most common type of lung cancer, is targeted therapy. However, a thorny problem with targeted therapy is the development of drug resistance in patients. Lee Mi-hyun, a pre-Korean medicine professor at…

Lung cancer is the leading cause of cancer deaths, with the highest mortality worldwide. Specifically, adenocarcinoma is the most common, which shows no obvious symptoms and may have reached an advanced stage when detected. However, updated treatments may help improve a patient’s condition or even cure it. Symptoms of Advanced Lung Adenocarcinoma Are Not Obvious…

Cancer is the number one killer among Hong Kong citizens. According to the latest “Overview of HK Cancer Statistics of 2020” released by the Hong Kong Cancer Registry (HKCaR) of the Hospital Authority (HA), there were 34,179 new cancer cases in Hong Kong, that is, an average of 94 people were diagnosed with cancer every…

Lung cancer is the most common and fatal cancer. In 2020, there were more than 2 million new lung cancer cases and 1.79 million deaths worldwide. The latest research pointed out that berberine, an active ingredient extracted from the Traditional Chinese Medicine (TCM) Coptis chinensis, has anti-cancer effects. The research team converted them into berberine-phytantriol-loaded…

A blood test may help determine if nodules detected during CT scans are lung cancer, researchers report. Annual screenings of patients at high risk for lung cancer can catch tumors early and improve a patient’s long-term prognosis. However, low-dose computer tomography (LDCT) has a high false-positive rate that can lead to unnecessary biopsies. The researchers…

Lung cancer is the second most common cancer in the world, with an estimated 1.8 million deaths each year. In Hong Kong, it is the number one killer among all cancer types, with more than 4,000 new cases recorded every year. Professor Tony Mok Shu-kam of the Faculty of Medicine, of The Chinese University of…